The VR Foundation Board of Directors today announced the resignation of Igor Korobko, PhD, DSci, who has served as Chief Scientific Director of the organization since it's inception. Dr. Korobko had informed the Board he intended to resign and focus on his academic career at the end of 2016. And he felt that moving up his resignation date to after the AAD Congress in early March of 2017 would allow VRF to complete the ongoing projects and to facilitate VRF’s continuing focus on its broader mission.
While the Board has the utmost regard for Dr. Korobko’s skills, professionalism and integrity, it accepted his resignation. The Board expressed its gratitude to Dr. Korobko for his unparalleled service as the Chief Scientific Director.
Among the many accomplishments of VRF under his scientific leadership was the development, in 2011, of the first comprehensive Vitiligo Electronic Health Record and Vitiligo Biobank Network, the translation of science into clinical interventions and drug repurposing, and regular Quarterly Reports. “We are grateful for Dr. Korobko’s distinguished tenure and numerous contributions,” the Board said. “Our non-profit organization has been very fortunate to have Dr. Korobko as Chief Scientific Director for so many years, and we wish him well.”
Dr. Korobko will continue his academic research as a Deputy Director and Head of the lab at the Institute of Gene Biology in Moscow, Russia. The Board will appoint a successor to the Chief Scientific Director in the near future.
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
The Step Up for Vitiligo Gala
Dallas-Fort Worth Vitiligo Support Group is organizing 'The Step Up for Vitiligo Gala' which will take place on April 28th in Austin, Texas at UT-Austin. Dr. Ammar Ah...28 April 2018 12:00, Austin, Texas at UT-Austin
11th session of the Conference of States Parties to the CRPD
The 11th session Convention on the Rights of Persons with Disabilities (CRPD) will take place at the United Nations Headquarters, New York, from 12 to 14 June 2018. Mo...12 June 2018 09:00, UN Plaza, New York
Can chemicals cause vitiligo?
It’s important to remember there are multiple factors involved in vitiligo onset, including genetic predisposition, living and working environments, and exposure to ce...
I have a new job - should I tell colleagues about my vitiligo?
If you are starting a new job and you are concerned about stares and questions about your skin, try a proactive approach. When the time is right and you are feeling co...
Can Scenesse be used for vitiligo treatment?
The drug Scenesse from Clinuvel has been tested in clinical trials for vitiligo, in combination with narrowband UVB. The new drug acts as an anti-oxidant and activates...